[Experimentation with Di Bella polychemotherapy in Tuscany]

Area of Science:

• Oncology
• Clinical Research
• Unconventional Medicine

Background:

• The Di Bella Treatment is an unconventional approach to cancer care.
• Its efficacy for advanced cancer patients has not been widely established.
• This study examines its application in Tuscany, Italy.

Purpose of the Study:

• To evaluate the clinical experience and outcomes of the Di Bella Treatment in advanced cancer patients.
• To analyze treatment response, survival, and progression in patients receiving this therapy.

Main Methods:

• A total of 641 advanced cancer patients were included across three study types: phase II, observational, and distributional.
• Data were collected and analyzed centrally.
• Kaplan-Meier Method was used to calculate survival and progression times.

Main Results:

• No objective treatment responses were observed.
• 63 patients (9.8%) achieved stable disease.
• Median overall survival was 4.5 months, and median time to disease progression was 2.7 months.
• Treatment interruption rates due to death, refusal, or toxicity were similar between observational and distributional groups.
• Progressive disease rates differed significantly (52% observational vs. 18% distributional).
• Lost to follow-up was notably high in the distributional study (40%).

Conclusions:

• The Di Bella Treatment did not demonstrate objective responses in this cohort of advanced cancer patients.
• Survival and progression metrics were modest, suggesting limited efficacy.
• Further investigation is warranted, particularly concerning the high rate of lost follow-ups in certain study arms.